Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,008
+$3,015 QoQ
Shares Held
10,719
+5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#385
of 639 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $318,191,174 across 30 Drug Manufacturers - Specialty & Generic names. HLN ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,839,811 | $132,208,811 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
127,125 | $68,880,136 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
785,524 | $26,613,551 | |
| 4 | VTRS |
Viatris Inc
|
1,518,578 | $24,115,016 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
632,408 | $21,925,584 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
115,990 | $19,548,952 | |
| 7 | LQDA |
Liquidia Corp
|
117,620 | $9,377,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
20,539 | $2,278,595 |
All Filings in HLN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,008 | 10,719 | Shares | Defined | 2026-08-14 | |
| 2024-12-31 | $96,993 | 10,167 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $160,551 | 15,175 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $296,335 | 35,876 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $130,975 | 15,427 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $150,238 | 18,255 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $121,518 | 14,588 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $107,618 | 13,221 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||